Eisai's Fycompa for Adjunctive Treatment of Partial Onset Seizures Launched in China Eisai Jan 06, 2020 08:57 HKT/SGT Read More
Gilead and Eisai Enter Into Agreement in Japan for the Co-Promotion of the Investigational Rheumatoid Arthritis Therapy Filgotinib, Pending Regulatory Approval Eisai Dec 24, 2019 16:22 HKT/SGT Read More
U.S. FDA Approves Eisai's Dayvigo (Lemborexant) for Treatment of Insomnia in Adult Patients Eisai Dec 23, 2019 08:17 HKT/SGT Read More
NTT DOCOMO to Absorb docomo Healthcare in Simplified, Short-form Merger NTT DOCOMO Dec 20, 2019 17:01 HKT/SGT Read More
Holista Files Patent for Water-Soluble Technology Targeting Cannabidiol (CBD) and Other High-Value, Fat-Soluble Nutraceuticals Holista CollTech Ltd Dec 12, 2019 13:00 JST Read More
Commencement of Major Renovation of Tsukuba Research Laboratories as Eisai Global Drug Discovery Center Aiming for Connecting Human and Human, and Data, and the World Eisai Dec 10, 2019 08:02 HKT/SGT Read More
Sysmex Presents Academic Report with a View to Creating a Simple Method of Diagnosing Alzheimer's Disease Using Blood Eisai Dec 09, 2019 08:36 HKT/SGT Read More
Eisai Satisfies All-Case Surveillance Condition for Approval of Anti-Cancer Agent Lenvima in Treatment of Thyroid Cancer Eisai Dec 09, 2019 08:17 HKT/SGT Read More
Hitachi to Provide CNAO with Proton Therapy System Hitachi, Ltd. Dec 06, 2019 18:16 HKT/SGT Read More
Eisai to Present New Research on Eribulin (Halaven) at 42nd Annual San Antonio Breast Cancer Symposium Eisai Dec 05, 2019 08:11 HKT/SGT Read More
エーザイ、第12回アルツハイマー病臨床試験会議（CTAD）においてアルツハイマー病／認知症領域の開発品に関する最新データを発表 Eisai Dec 02, 2019 09:00 JST Read More
Eisai to Present Latest Data on Alzheimer's Disease / Dementia Pipeline at 12th Clinical Trials on Alzheimer's Disease Conference Eisai Dec 02, 2019 08:23 HKT/SGT Read More
